| HS Code | 868903 |
| Chemical Name | Betaine Hydrochloride |
| Cas Number | 590-46-5 |
| Molecular Formula | C5H12ClNO2 / C5H11NO2·HCl |
| Molecular Weight | 153.61 g/mol |
| Appearance | White crystalline powder or colorless crystals |
| Assay Content | 98.0%-100.5% as betaine hydrochloride on dried basis |
| Ph | 1% aqueous solution is strongly acidic, approximately pH 1.0-2.0 |
| Solubility | Freely soluble in water; slightly soluble in ethanol; practically insoluble in ether |
| Melting Point | About 293°C with decomposition |
| Particle Size | Typically 80-200 microns, customizable for tablet/capsule/premix/solution applications |
| Bulk Density | Approximately 0.55-0.70 g/mL depending on grade and lot |
| Veterinary Grade | Yes |
| Suitable Dosage Forms | Tablets, Injections, Capsules, Powders, Granules, Premix, Solutions |
| Storage Conditions | Store in a cool, dry, airtight container; protect from light and moisture |
| Shelf Life | 24 to 36 months in unopened original packaging under recommended conditions |
As an accredited Betaine Hydrochloride Premix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Packaging: 25 kg fiber drums with double polyethylene liners, tamper-evident seals, and veterinary API labeling for tablets, injections, capsules, powders, granules, premix, solutions. |
| Container Loading (20′ FCL) | 20′ FCL container loaded with Betaine Hydrochloride Premix, packed in sealed drums/pallets, safely secured for veterinary transport. |
| Shipping | Betaine Hydrochloride Premix (Veterinary Grade API) ships in sealed, moisture-proof containers with tamper-evident packaging. Transport requires cool, dry conditions away from direct sunlight and incompatible substances. Standard air, sea, or road freight is acceptable with proper documentation, safety data sheet, and country-specific import compliance. |
| Storage | Store Betaine Hydrochloride Premix in a cool, dry, well-ventilated area, away from direct sunlight, moisture, and heat. Keep the original container tightly closed when not in use. Protect from incompatible materials and contamination. Ensure storage conditions comply with veterinary API guidelines to maintain stability, potency, and product quality throughout shelf life. |
| Shelf Life | Shelf life is typically 24 months when stored in original containers under cool, dry conditions away from light and moisture. |
During direct compression of high-dose betaine hydrochloride veterinary tablets, the crystalline material is often pre-milled to a d90 below 250 µm and blended with anhydrous citric acid, sodium bicarbonate, and PEG 6000 before slugging or dry granulation. The hydrochloride salt dissociates in aqueous media to release the betaine zwitterion and chloride; the acidified local pH during dissolution can promote effervescent tablet disintegration and mask bitter organoleptic notes in oral dosage forms. Loss on drying for the blend is typically controlled below 0.5% because free moisture initiates precompression reaction between bicarbonate and acid components. Rotary tablet presses operating at 20–35 kN compression force are used; tablet hardness is maintained between 60 N and 90 N to balance breakage during foil packaging against disintegration time. Friability testing follows USP <1216>; tablets are rejected if friability exceeds 1.0%. Content uniformity is assessed on 10 tablets at start, middle, and end of the compression run according to USP <905>; an acceptance value of not more than 15 is required for the 500 mg dose. The terminal product is a 500 mg betaine HCl effervescent tablet intended for dilution in drinking water for ruminants or swine. For moisture protection, cold-formed aluminium foil blisters with desiccant sachets are specified when storage humidity exceeds 60% RH. Published data for species-specific therapeutic dosing in this exact effervescent presentation is limited; formulators therefore use pilot-scale dissolution curves and feed refusal checks rather than fixed monograph dosing.
Betaine hydrochloride premix is commonly extended onto ground maize cob, wheat bran, or precipitated silica in a horizontal ribbon blender with a working volume of 60–80% of nominal capacity. The salt is fine and dense; the bulk density typically ranges from 0.65 g/cm³ to 0.85 g/cm³ depending on particle size distribution and carrier selection. When added at 5% to 20% betaine HCl active concentration in premix, the initial spray or scoop addition creates high local chloride concentration. This can promote caking if ambient relative humidity remains above 65% RH for more than 4 hours. Therefore the mixing step is time-limited and the discharge hopper is fitted with vibrating pads. Homogeneity is verified by collecting 10 samples per batch according to ISO 6497 and analyzing chloride or betaine by ion chromatography or HPLC; a coefficient of variation below 5% is considered acceptable for feed additive premixes. The premix is then incorporated into complete feed at 0.1% to 0.3% betaine base equivalents for monogastric methyl donor supply. The terminal product is a 25 kg paper-lined woven bag with inner polyethylene liner, labelled for poultry, swine, and aquaculture feed mill use. Carryover cleaning is mandatory when the same line processes coccidiostats or cationic surfactants because chloride residues may cross-contaminate ion-sensitive formulations.
| Dosage form | Critical attribute | Test method or standard | Typical acceptance limit |
|---|---|---|---|
| Effervescent tablet | Friability | USP <1216> | ≤ 1.0% |
| Immediate-release capsule | Dissolution | USP <711> | Q ≥ 80% at 30 min in 900 mL water |
| Feed premix | Mixing homogeneity | ISO 6497 | CV ≤ 5% |
| Oral drinking-water solution | Preservative efficacy | Ph. Eur. 5.1.3 | log reduction per category 1–3 at 7 days |
| Parenteral solution | Bacterial endotoxins | Ph. Eur. 2.6.14, Ph. Eur. 5.1.10 | limit calculated from maximum intended bolus dose |
| Top-dress granules | Bulk density | USP <616> Method I | 0.55 g/mL–0.75 g/mL |
| Aquafeed pellet | Water leach loss | in-house immersion test | ≤ 10% dry matter loss at 30 min |
Intravenous or subcutaneous formulations containing betaine hydrochloride require a parenteral-grade source with bacterial endotoxins controlled by limulus amoebocyte lysate testing per Ph. Eur. 2.6.14; the acceptance limit is calculated from the maximum intended bolus dose according to Ph. Eur. 5.1.10. The active is dissolved in water for injection at 25°C under nitrogen purging, and the pH is adjusted with dilute hydrochloric acid or sodium hydroxide to 5.0–6.5. Because betaine HCl is highly water-soluble, a 5% w/v solution can be prepared without co-solvents; however, the solution must be filtered through a 0.22 µm PVDF membrane to reduce bioburden before terminal steam sterilisation at 121°C for 15 minutes. The hydrochloride form contributes chloride ion; therefore the final isotonicity adjustment with sodium chloride must account for the measured osmolality, target range 280–320 mOsm/kg for subcutaneous injection in companion animals. Sterility testing follows Ph. Eur. 2.6.1; particulate contamination is assessed per Ph. Eur. 2.9.19. Glass ampoules are preferred over polymer vials when long-term storage exceeds 24 months because chloride stress cracking in certain polyolefin grades has been observed in stability chambers. Published data for specific injectable veterinary betaine HCl monographs is limited; sterility, pyrogenicity, and particulate limits are therefore derived from general parenteral compendial requirements rather than species-specific pharmacopoeial monographs.
For companion animal capsules, betaine hydrochloride is often formulated as a direct-fill powder blend using microcrystalline cellulose and magnesium stearate rather than wet granulation because the salt becomes sticky at moisture contents above 4% w/w. The blend is passed through a 0.8 mm conical mill to break agglomerates, then filled into size 0 or size 1 hard gelatin capsules using a tamping pin machine at 80% relative fill volume. Dissolution testing follows USP <711> Apparatus 2 at 50 rpm in 900 mL water; a Q value of 80% at 30 minutes is commonly applied for immediate-release veterinary capsules, but the exact specification must be justified by the target species gastrointestinal pH. Capsule storage requires aluminium/PVC/Aclar blister packaging when the warehouse dew point exceeds 12°C because gelatin shell cross-linking and content clumping accelerate above 60% RH. The terminal product is used in dogs and cats for methyl donor support during hepatic lipidosis or as part of homocysteine management, though published dose-response data in these species is limited. Batch records include loss on drying by Ph. Eur. 2.2.32 at 105°C and microbial limits by Ph. Eur. 2.6.12 and Ph. Eur. 2.6.13. If a vegan or moisture-resistant capsule is required, hydroxypropyl methylcellulose capsules are substituted, but hygroscopic fill weight must be revalidated because HPMC swells faster than gelatin in high-humidity conditions.
Oral solutions containing betaine hydrochloride for poultry drinking water are prepared as a 25% w/v concentrated stock solution in 1000 L high-density polyethylene IBCs with bottom conical discharge to avoid dead-leg microbial growth. The solution is acidified to pH 3.0–4.0 with organic acid blends to suppress pathogen regrowth and improve palatability; potassium sorbate is added at 0.1% w/v as a preservative when the stock solution is not used within 72 hours. Continuous dosing pumps calibrated to 1% to 3% of daily water intake deliver the product into nipple drinkers, but hard water above 250 mg/L calcium carbonate creates salt scale at the dosing point. Therefore in-line filters of 125 µm are installed before the medicator in field installations. The terminal solution is packed in 5 L and 20 L jerry cans with tamper-evident caps. Stability testing follows ICH Q1A under long-term conditions of 25°C/60% RH and accelerated conditions of 40°C/75% RH; the product is protected from light because ultraviolet exposure can reduce betaine assay by an unspecified interval when stored in unpigmented translucent containers. Published data for light-induced degradation in this specific matrix is limited; amber polyethylene terephthalate is therefore selected as a conservative packaging material.
Feed top-dress powders are manufactured by low-shear ploughshare mixing of betaine HCl with lactose monohydrate, colloidal silicon dioxide, and apple flavour. The cohesive powder is subsequently compacted in a dry granulator at roll pressure 30–50 bar, and the ribbons are milled through a 1.0 mm square-hole screen. The resulting granules are sieved to retain the 100–500 µm fraction; fines below 100 µm are recycled at no more than 20% of fresh feed to prevent granule hardness drift. Bulk density is tested according to USP <616> Method I, with an acceptance range of 0.55 g/mL to 0.75 g/mL to ensure consistent scoop fill. A 5 g top-dress dose is metered into individual sachets on a vertical form-fill-seal line with nitrogen flushing; residual oxygen is kept below 2% by headspace analyser. The terminal product is applied to swine or cattle feed immediately before feeding. Segregation potential is assessed using a 10-minute vibratory shaker test at 1.5 mm amplitude; samples from top, middle, and bottom of the hopper must not differ by more than 5% betaine assay. Packaging is kept below 30 kg net weight per carton to avoid compaction during warehouse stacking. If the product is stored at temperatures above 35°C, granule friability increases and capping of the sachet seal is more frequent on vertical machines.
Through a steam-conditioned pellet mill, feed containing betaine HCl premix is exposed to 80°C to 85°C for 20–30 seconds before extrusion through a 3 mm die. The hydrochloride salt is stable under these short residence times, but the in-line moisture addition of 2% to 3% can lower die throughput if the premix carrier is poorly bound. Therefore aquafeed formulators use a carrier system with 70% wheat middlings and 30% calcium carbonate to reduce sticking on the die face. Post-pelleting retention of betaine is checked by methanol extraction and LC-MS/MS; published recovery data for this specific carrier combination is limited, so each mill typically runs a mass-balance validation across three production batches. Pellets are cooled in a counterflow cooler to 5°C above ambient before bagging. The terminal product is a sinking or floating aquafeed pellet for carp, tilapia, or shrimp; the betaine HCl acts as a methyl donor and osmolyte. In shrimp feeds, inclusion is evaluated at 0.1% to 0.5% to support osmotic balance during low-salinity transfer. Because the salt is water-soluble, pellet water stability tests must include leach loss measurement; a 30-minute leach loss below 10% of pellet dry matter is used as a control point in many aquafeed mills.
Competitive Betaine Hydrochloride Premix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Betaine Hydrochloride Premix Veterinary Grade API for Tablets / Injections / Capsules / Powders / Granules / Premix / Solutions is supplied under the manufacturer-specific model identifier BHC-VET-PMX. The active constituent is trimethylglycine hydrochloride, C5H11NO2·HCl, CAS 590-46-5, with a molecular mass of 153.61 g/mol. The material is a white to off-white crystalline powder intended as an active pharmaceutical ingredient in licensed veterinary oral solids, parenteral solutions, and medicated premixes. The premix grade is differentiated from unprocessed betaine hydrochloride by controlled granulometry, residual moisture, bulk and tapped density, elemental impurity limits, and optional endotoxin controls. The designation is assigned by the manufacturer; a release protocol should include the marketing authorization number, batch identity, retest date, and the monograph revision applied.
Betaine hydrochloride dissociates in aqueous media to yield the betaine zwitterion and chloride. This dissociation creates an acidic pH in unbuffered solution; a 1% solution typically measures pH 1.0–2.0 by USP <791>. The chloride fraction is 23.1% by mass, which is important when formulating for species with low chloride tolerance or when calculating total dietary chloride in premix applications. As a methyl donor, betaine participates in the remethylation of homocysteine to methionine through betaine-homocysteine methyltransferase, a pathway distinct from choline-dependent methylation.
The hydrochloride salt is not simply a protonated form of betaine; it introduces a stoichiometric chloride load and a pronounced aqueous acid reaction that must be handled in buffer design. In tablet and capsule manufacturing, the acidic surface can interact with carbonate fillers and with moisture films on tooling. In injectable and solution forms, the pH drop is rapid unless a buffer is added before other excipients. The comparative profile against betaine anhydrous and choline chloride is provided in the following matrix.
| Parameter | Betaine HCl premix | Betaine anhydrous | Choline chloride |
|---|---|---|---|
| CAS registry | 590-46-5 | 107-43-7 | 67-48-1 |
| Molecular mass | 153.61 g/mol | 117.15 g/mol | 139.62 g/mol |
| Chloride mass fraction | 23.1% | 0% | 25.4% |
| Methyl donor entry | Direct via betaine-homocysteine methyltransferase | Direct via betaine-homocysteine methyltransferase | Indirect; requires choline dehydrogenase and betaine aldehyde dehydrogenase |
| Aqueous acidifying effect | Pronounced; hydrochloride dissociation | Minimal; zwitterionic | Moderate to low; quaternary ammonium chloride |
These differences influence more than labeling. Betaine HCl can be selected when acidification is desired in non-ruminant diets, but the same acid functionality creates incompatibility with alkaline carriers used in feed premixes. Betaine anhydrous does not supply hydrochloric acid and is preferred when chloride load must be minimized, while choline chloride provides methyl groups only after two-step oxidation. Published data for this specific configuration is limited where species-specific methyl-donor comparisons are made.
A representative release specification for model BHC-VET-PMX is shown below. The criteria are typical for a veterinary premix/API grade intended for multiple dosage forms; the receiving marketing authorization may impose tighter limits for residues, microbial quality, or particle size.
| Parameter | Acceptance criterion | Reference method |
|---|---|---|
| Appearance | White to off-white crystalline powder | Visual |
| Assay on dried basis | 98.0–102.0% | Non-aqueous titration |
| Loss on drying | ≤0.5% | USP <731> |
| Residue on ignition | ≤0.1% | USP <281> |
| pH of 1% solution | 1.0–2.0 | USP <791> |
| Particle size D50 | 150–250 µm | Laser diffraction, USP <429> |
| Particle size D90 | ≤500 µm | Laser diffraction, USP <429> |
| Bulk density | 0.55–0.75 g/mL | USP <616> Method I |
| Tapped density | 0.65–0.90 g/mL | USP <616> |
| Residual solvents | Class 3 only, per USP <467> | Headspace GC |
| Elemental impurities | Per USP <232>/USP <233> veterinary acceptance criteria | ICP-MS |
The particle-size window is designed for both direct compression and dry powder blending. A D50 below 100 µm may increase dusting and reduce flow, while a D90 above 500 µm can produce content uniformity failures in low-dose tablet blends. The bulk-density range supports auger-filling lines; variation outside 0.55–0.75 g/mL can alter fill weights on volumetric equipment. Because the material is hygroscopic, storage temperature is controlled below 25°C and relative humidity below 60%. At RH above 60%, surface moisture adsorption alters flow and increases punch-face adhesion; re-drying to LOD ≤0.3% is required before compression.
Residual solvent testing per USP <467> is included because recrystallization from alcoholic or ketonic systems can leave traces that are not acceptable in injectable products. Elemental impurities are controlled by ICP-MS after microwave digestion per USP <233>; veterinary acceptance criteria are applied under USP <232> rather than a single heavy-metal color comparison. For injectable-grade lots, bacterial endotoxin testing per USP <85> is performed when the marketing authorization includes parenteral routes.
In oral solid operations, the premix grade is usually blended with microcrystalline cellulose, crospovidone or sodium starch glycolate, and a lubricant. The lubricant is added at 0.25–0.5% w/w for 3–5 min; higher levels or extended blending reduce tablet hardness. The compression suite is maintained at 35–45% RH and 20–25°C to limit water film formation. Production-scale experience with rotary tablet presses indicates that punches and dies foul rapidly when the feed frame is overfilled or when the API lot has LOD above 0.5%.
When dry granulation is required, a roller compactor fitted with a 0.8–1.25 mm screen is used. Wet granulation with water-rich binders is generally avoided because the highly water-soluble surface dissolves and forms hard agglomerates. If wet granulation is unavoidable, a hydroalcoholic binder with water content below 10% and fluid-bed drying at inlet air temperature below 50°C provide the narrowest process window. For capsule filling, the powder or granule is loaded into tamping-pin or dosator machines. The tapped-density range permits compact filling, but hygroscopicity requires a dry-air purge at ≤35% RH around the powder hopper.
For injectable and solution dosage forms, the API is dissolved in Water for Injection and buffered to pH 4.0–5.0 before adding tonicity agents or preservatives. Dissolution of the hydrochloride salt in unbuffered water produces a pH below 3.0; direct parenteral use of unbuffered solution is outside the expected tissue-compatible range. Bicarbonate and carbonate buffers are incompatible because they evolve carbon dioxide. Acetate or citrate buffers are used. Terminal sterilization at 121°C for 15 min is validated only within the buffered pH range; acid-catalyzed degradation in unneutralized solution may occur during repeat autoclave cycles. Filter sterilisation through 0.22 µm PVDF or PES membranes is appropriate for heat-sensitive formulations. The final solution should avoid contact with strong oxidizing agents and should be protected from repeated headspace air ingress. Published data for this specific configuration is limited.
The hydrochloride form remains chemically stable under dry heat at 70–90°C for short intervals, but hygroscopic degradation is the primary stability risk. In feed pelleting, the material is exposed to steam-conditioned moisture at 70–90°C; this can cause surface dissolution and hopper bridging rather than chemical loss. Packaging for bulk shipment should use high-density polyethylene drums with heat-sealed aluminum-foil liners and a desiccant unit. For repeated dispensing, a container with activated silica or molecular-sieve sachets should maintain the headspace dew point below -10°C. Unopened containers stored at ≤25°C and ≤60% RH are assigned a retest date rather than a fixed expiry unless stability data support a longer shelf life.
In dry premix operations, the acidic surface of betaine HCl readily reacts with carbonate carriers such as limestone or oyster shell; the release of carbon dioxide and moisture produces caking and may reduce homogeneity. Non-reactive carriers such as dry corn cob, rice hulls, or dextrose should be used. Horizontal ribbon mixers operating at 10–20 rpm for 10–15 min are generally sufficient, but the coefficient of variation should be confirmed by a suitable analytical finish. Equipment contact surfaces should be 316L stainless steel or polymer-lined because repeated contact with the acidic powder can corrode carbon steel. In multi-component premixes containing choline chloride, the two hygroscopic chloride salts should be blended in separate phases to avoid localized moisture transfer and clumping.